Current and future therapeutic strategies for Alzheimer’s disease: an overview of drug development bottlenecks

Alzheimer’s disease (AD) is the most common chronic neurodegenerative disease worldwide. It causes cognitive dysfunction, such as aphasia and agnosia, and mental symptoms, such as behavioral abnormalities; all of which place a significant psychological and economic burden on the patients’ families....

Descripción completa

Detalles Bibliográficos

Autores principales:	Yong Peng, Hong Jin, Ya-hui Xue, Quan Chen, Shun-yu Yao, Miao-qiao Du, Shu Liu
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2023-08-01
Colección:	Frontiers in Aging Neuroscience
Materias:	Alzheimer’s disease β-amyloid protein tau protein mitochondria-targeting multi-targets clinical trials
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fnagi.2023.1206572/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!